Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02343718
Title Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Age Groups: child
Covered Countries CAN

No variant requirements are available.